Study: People With Both Hay Fever and Asthma at Lower Risk of Colorectal … – Becker’s ASC Review

Study: People With Both Hay Fever and Asthma at Lower Risk of Colorectal
Becker’s ASC Review
The results of a new study indicate that people with both hay fever and asthma are at lower risk of developing colorectal cancer, according to a news release. Data from the study was presented at 11th Annual American Association for Cancer Research

and more »

View full post on asthma – Google News

Revolution Season 1 Review “No Quarter” – In Which the Most Effective Weapon … – TV Equals


TV Equals

Revolution Season 1 Review “No Quarter” – In Which the Most Effective Weapon
TV Equals
Revolution Season 1 Review “No Quarter” – In Which the Most Effective Weapon is Asthma. This week on Revolution in 'No Quarter', Charlie, Miles and Nora try to help the members of a rebel base that's under siege; Aaron and Maggie explore Grace's house
'Revolution' Recap: The Bridge on the River Why?New York Post
'Revolution' Season 1 Episode 3: 'No Quarter'TheCelebrityCafe.com
'Revolution' Recap (Season 1, Episode 3): “No Quarter”The Faster Times

all 33 news articles »

View full post on asthma – Google News

Exposure To Common Toxic Substances Could Increase Asthma Symptoms – Eurasia Review


Eurasia Review

Exposure To Common Toxic Substances Could Increase Asthma Symptoms
Eurasia Review
Children who are exposed to polychlorinated biphenyls (PCBs), which were commonly used in a range of industrial products, could be at risk of an increase in asthma symptoms, according to new research. The study will be presented in a poster discussion
PCB Exposure Increases Asthma Risk in ChildrenMedical Daily
Exposure to common toxic substances may up kids` asthma symptomsZee News

all 12 news articles »

View full post on asthma – Google News

“Asthma Global Clinical Trials Review, H1, 2012” Now Available at Fast Market … – SBWire (press release)

"Asthma Global Clinical Trials Review, H1, 2012" Now Available at Fast Market
SBWire (press release)
Boston, MA — (SBWIRE) — 07/24/2012 — GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H1, 2012" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the

and more »

View full post on asthma – Google News

AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma – Pharmaceutical Business Review

AstraZeneca Symbicort shows similar safety profile as Budesonide for asthma
Pharmaceutical Business Review
AstraZeneca has published a new study that demonstrates that Symbicort Inhalation Aerosol 320/9 µg twice daily has a safety profile similar to Budesonide pressurized metered-dose inhaler (pMDI) 320 µg twice daily for asthma.
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows EON: Enhanced Online News (press release)

all 2 news articles »

View full post on asthma – Google News